Can Lactobacillus plantarum be used to improve symptoms of attention‑deficit/hyperactivity disorder or autism spectrum disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Lactobacillus plantarum Help with ADHD or Autism?

Yes, Lactobacillus plantarum shows promise for improving hyperactivity-impulsivity symptoms in younger children with ADHD and autism spectrum disorder (ASD), though evidence remains preliminary and benefits appear most pronounced in children under 12 years old.

Evidence for Autism Spectrum Disorder

Core Symptom Improvements

  • L. plantarum PS128 specifically demonstrates beneficial effects in children with ASD, particularly for opposition/defiance behaviors and overall symptom severity as measured by standardized scales 1.

  • A real-world study of 131 autistic children found that patients taking L. plantarum PS128 had greater improvements and fewer side effects than those taking other probiotics, with more evident positive effects in younger children 2.

  • The most recent 2025 randomized controlled trial using Lactiplantibacillus plantarum combined with Levilactobacillus brevis showed improved hyperactivity-impulsivity in younger children with ASD (Cohen's d = 1.245) and better quality of life comfort scores 3.

Gastrointestinal and Behavioral Mechanisms

  • Animal studies demonstrate that L. plantarum N-1 supplementation rescues autism-like behaviors including anxiety and depression while reversing intestinal flora structure by enhancing beneficial microorganisms like Allobaculum and Oscillospira 4.

  • The gut-brain axis dysregulation seen in neurodevelopmental disorders may be modulated through probiotic effects on the microbiome, which influences endocrine, neural, and immune pathways 5.

Evidence for ADHD

Executive Function and Symptom Control

  • The most recent 2026 trial showed probiotics (L. Acidophilus, B. Lactis, B. Longum) significantly improved executive function scores in children with ADHD after 2 months compared to placebo (151.50 vs. 190.68, p < 0.001) 6.

  • A 2025 study using L. plantarum PTCC 1896 with B. animalis demonstrated significant decrease in Conners' Parent Rating Scale total score after 4 weeks and improved auditory response control after 8 weeks when combined with Ritalin 7.

  • The 2025 pilot study found improved hyperactivity-impulsivity symptoms in younger children with ADHD (Cohen's d = 0.692) receiving L. plantarum and L. brevis 3.

Clinical Recommendations

Age-Specific Considerations

  • Target younger children (ages 7-12) preferentially, as age-stratified analyses consistently show more robust improvements in this demographic across multiple studies 3, 1, 2.

  • Benefits appear to diminish or become less consistent in adolescents, suggesting a developmental window for optimal probiotic intervention 3.

Strain Selection

  • Prioritize L. plantarum PS128 for ASD based on multiple positive trials and real-world evidence showing superiority over other probiotic strains 1, 2.

  • For ADHD, consider combinations including L. plantarum with Bifidobacterium species (B. lactis, B. animalis, B. longum) as these showed executive function improvements 7, 6.

  • Dosing typically ranges from 10^9 CFU/daily, with treatment durations of 4-12 weeks showing measurable effects 3, 7, 1.

Integration with Standard Treatment

  • Probiotics appear most effective as adjunctive therapy rather than monotherapy, particularly when combined with standard ADHD medications like methylphenidate 7.

  • The mechanism likely involves dopamine and gamma-aminobutyric acid production by specific probiotic strains, complementing conventional pharmacotherapy 3.

Important Caveats

Evidence Quality Limitations

  • Despite promising results, a 2025 systematic review concluded that inconsistencies among studies and methodological limitations prevent solid conclusions regarding probiotic efficacy in ASD 8.

  • Most studies have small sample sizes (30-80 participants) and relatively short intervention periods (4-12 weeks), limiting generalizability 3, 7, 1.

Safety Profile

  • Probiotics demonstrate excellent safety with very few adverse events in otherwise healthy children with neurodevelopmental disorders 3, 7, 1.

  • However, existing guidelines caution that probiotics should be avoided in severely debilitated or immunocompromised children with risk factors like central venous catheters 9.

Outcome Variability

  • Benefits are primarily seen in hyperactivity-impulsivity domains and quality of life measures, with less consistent effects on core social communication deficits in ASD 3, 1.

  • Parent-reported outcomes show more consistent improvements than objective neuropsychological testing, suggesting potential reporting bias 3.

Practical Implementation

Start with L. plantarum PS128 at 10^9 CFU daily for 8-12 weeks in children ages 7-12 with ASD or ADHD, monitoring for improvements in hyperactivity, impulsivity, and behavioral symptoms using standardized rating scales 3, 1, 2. For ADHD specifically, consider combination products with Bifidobacterium species as adjunctive therapy to standard medications 7, 6. Younger children show more robust responses, so prioritize this intervention in elementary school-aged patients rather than adolescents 3, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.